Virtual biotech company puts thousands of AI scientist agents to work

Stanford researchers have built a virtual biotech company staffed by 37,000 AI agents that handle the entire drug discovery process, from identifying targets to designing clinical trials. The AI analyzed 50,000 clinical trials in under a week, uncovering biological patterns that predict drug success. It also independently designed a lung cancer therapy that a major pharmaceutical company later developed, earning FDA breakthrough designation.